Scarica l'app Stockscreener
13.84
0.80%
0.11
Pre-mercato:
13.83
-0.010
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VTYX Giù?
Forum
Previsione
Ventyx Biosciences Inc Borsa (VTYX) Ultime notizie
Will Ventyx Biosciences Inc. stock split attract more investorsStock Surge & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
Lilly To Buy Ventyx Biosciences For $1.2 Billion To Expand Oral Inflammation Pipeline - Pulse 2.0
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc.VTYX - PR Newswire
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Ventyx Biosciences, Inc. (NASDAQ: VTYX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - PR Newswire
Ventyx Biosciences to be Sold to Eli Lilly for $14 per Share - Intellectia AI
Wilson Sonsini Advises Ventyx Biosciences on $1.2 Billion Acquisition by Eli Lilly - Wilson Sonsini
UBS downgrades Ventyx Biosciences stock to Neutral on Eli Lilly acquisition By Investing.com - Investing.com Nigeria
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B - BioWorld MedTech
FDA Limits Oversight of Fitness Wearables as Eli Lilly Acquires Ventyx Biosciences in $1 Billion Deal - geneonline.com
2 Firms Guide Eli Lilly's $1.2B Ventyx Biosciences Acquisition - Law360
Lilly Snags Ventyx For $1.2 Billion; Who Else Benefits? - Investor's Business Daily
Eli Lilly Scoops Up Ventyx Biosciences in $1.2 Billion Acquisition - NAVLIN DAILY
Lilly’s Ventyx Buyout Will Swell Interest In NLRP3 inhibitors - Citeline News & Insights
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Ventyx Biosciences, Inc. (VTYX) - MarketScreener
Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition - MedCity News
Lilly buys Ventyx in $1.2bn deal to tackle chronic inflammation - BioXconomy
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences - PharmExec.com
Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal - TipRanks
Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal - Asianet Newsable
Ventyx Biosciences (VTYX) Downgraded by Wells Fargo to Equal-Wei - GuruFocus
Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1? - Yahoo Finance
Lilly to acquire Ventyx Biosciences stock for $14 per share - Investing.com
Lilly Agrees to Acquire Ventyx Biosciences - Contract Pharma
Eli Lilly stock pops in premarket on $1.2 billion Ventyx deal — what traders watch next - TechStock²
Lilly acquires inflammatory firm Ventyx Biosciences for $1.2bn deal - European Pharmaceutical Review
Eli Lilly stock to acquire Ventyx for $1.2 billion, Cantor Fitzgerald maintains Overweight rating - Investing.com
Lilly announces acquisition of Ventyx Biosciences for around $1.2bn - PMLiVE
VTYX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Ventyx Biosciences, Inc. is Fair to Shareholders - Bluefield Daily Telegraph
Ventyx Biosciences (VTYX) Stock Rally Cools as $1.2B Eli Lilly Takeover Triggers Target Cuts - TipRanks
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion to Expand Inflammatory Disease Portfolio - geneonline.com
Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact - BioSpace
Lilly buys inflammation biotech Ventyx for $1.2B in wake of Parkinson's, CV readouts - Fierce Biotech
Eli Lilly in Advanced Talks to Buy Ventyx for About $1 Billion - GuruFocus
Lilly confirms bid to acquire Ventyx Biosciences - The Pharma Letter
Eli Lilly acquires inflammatory specialist Ventyx for $1.2bn - Pharmaceutical Technology
Ventyx Biosciences jumps on report Eli Lilly nears more than $1B deal - MSN
Ventyx Biosciences downgraded to Hold from Buy at Canaccord - TipRanks
Ventyx Biosciences downgraded to Neutral from Buy at UBS - TipRanks
Lilly to acquire Ventyx Biosciences stock for $1.2 billion, Canaccord cuts rating - Investing.com Canada
UBS downgrades Ventyx Biosciences stock to Neutral on Eli Lilly acquisition - Investing.com Canada
Eli Lilly to acquire Ventyx Biosciences stock for $1.2 billion as Clear Street downgrades - Investing.com
Lilly Commits $1.2B to Transform Oral Therapy Landscape with Ventyx Acquisition - geneonline.com
Lilly Inks $1.2bn Deal For Ventyx In Broader Pipeline Expansion - Citeline News & Insights
Significant price jump for US biotech company - medwatch.com
Eli Lilly (LLY) to Acquire Ventyx Biosciences in $1.2 Billion De - GuruFocus
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - The Malaysian Reserve
Ventyx downgraded to Market Perform from Outperform at LifeSci Capital - TipRanks
Eli Lilly to Acquire Drug Developer Ventyx for $1.2 Billion, Expanding in Autoimmune Field - Bitget
Lilly to buy Ventyx Biosciences for $1.2 billion - Indian Pharma Post
Shareholder Alert: The Ademi Firm investigates whether Ventyx Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders - Morningstar
Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion, Expanding Inflammation Portfolio - NAI500
Confirming rumours, Lilly to buy Ventyx in $1.2B deal - FirstWord
Eli Lilly confirms plan to buy Ventyx Biosciences in $1.2 billion deal - MSN
Eli Lilly confirms deal to buy Ventyx Biosciences for $14 a share - MSN
Eli Lilly to buy Ventyx Biosciences for $1.2 billion - 104.1 WIKY
Eli Lilly (LLY) Acquires Ventyx Biosciences for $1.2 Billion - GuruFocus
Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14 - TechStock²
Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs - BioPharma Dive
Eli Lilly to buy Ventyx Biosciences for $1.2bn - MLex
Eli Lilly to Acquire Ventyx Biosciences in Cash Deal - TipRanks
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy - Bitget
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy By Reuters - Investing.com
Ventyx Biosciences Signs Multiple Material Agreements - TradingView — Track All Markets
Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus - TechStock²
Eli Lilly (LLY) Set to Acquire Ventyx Biosciences in Cash Deal - GuruFocus
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):